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ABSTRACT
Homing endonucleases recognize long target DNA
sequences generating an accurate double-strand
break that promotes gene targeting through hom-
ologous recombination. We have modified the
homodimeric I-CreI endonuclease through protein
engineering to target a specific DNA sequence
within the human RAG1 gene. Mutations in RAG1
produce severe combined immunodeficiency
(SCID), a monogenic disease leading to defective
immune response in the individuals, leaving them
vulnerable to infectious diseases. The structures of
two engineered heterodimeric variants and one
single-chain variant of I-CreI, in complex with a
24-bp oligonucleotide of the human RAG1 gene
sequence, show how the DNA binding is achieved
through interactions in the major groove. In
addition, the introduction of the G19S mutation in
the neighborhood of the catalytic site lowers the
reaction energy barrier for DNA cleavage without
compromising DNA recognition. Gene-targeting
experiments in human cell lines show that the
designed single-chain molecule preserves its
in vivo activity with higher specificity, further
enhanced by the G19S mutation. This is the first
time that an engineered meganuclease variant
targets the human RAG1 locus by stimulating hom-
ologous recombination in human cell lines up to
265bp away from the cleavage site. Our analysis
illustrates the key features for a ` la carte procedure
in protein–DNA recognition design, opening new
possibilities for SCID patients whose illness can be
treated ex vivo.
INTRODUCTION
The generation of DNA double-strand breaks (DSBs)
results in the activation of the DNA damage response.
DSBs can be repaired by two major mechanisms:
non-homologous end joining (NHEJ), an error-prone
pathway that may generate short insertions or deletions
at the cleavage site upon rejoining the ends of the DSBs,
or by homologous recombination (HR). In contrast to
NHEJ, HR uses a homologous DNA sequence as
template and therefore is essentially an error-free mech-
anism for DSB repair. However, if the template includes
extra sequences ﬂanked by the homologous regions,
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be used for exchanging genetic information between
endogenous and/or exogenous sequences (1). This charac-
teristic of HR can be exploited in gene therapy to promote
the exchange between an endogenous mutated chromo-
somal sequence and an exogenous repair DNA construct
for gene-correction purposes. However, to trigger this
mechanism, a very speciﬁc ‘tool’ that would provide a
speciﬁc DSB close to or in the area of interest is essential.
In the search to generate such an efﬁcient and speciﬁc
‘tool’, homing endonucleases (HE) have emerged as
perfect candidates due to their high speciﬁcity ( 12-bp
target sequences), their low cleavage frequency in
eukaryotic genomes and the fact that their action
actively induces HR (2). Although several hundreds of
HEs have been identiﬁed, the repertoire of cleavable
sequences is limited. Consequently, HE engineering
aimed at increasing the repertoire of recognized DNA
sequences is necessary to obtain variants capable of accur-
ately cleaving chosen sequences. Chimeric endonucleases
resulting from the fusion of engineered zinc-ﬁnger
domains with the catalytic domain of the FokI restriction
enzyme have been used to induce targeted recombination
in endogenous genes in human cells, Drosophila, plants,
ﬁsh and other organisms (3–6). In a totally different
approach, triplex-forming oligonucleotides (TFOs) have
been conjugated with restriction enzymes (7) to target
their cleavage activity to speciﬁc long sequences. The
recent development of adapted protein-engineering
strategies (8) has paved the way for the development of
tailored endonucleases derived from natural HEs.
I-CreI is a well-characterized homodimeric member of
the LAGLIDADG family of HE (9). This enzyme cleaves
a 22-bp pseudo-palindromic target and, due to its large
recognition sequence, minimizes the probability of
generating nonspeciﬁc DSB in a mammalian genome,
opening up the possibility to customize the enzyme for
therapeutic purposes. The analysis of I-CreI bound to its
natural target depicted the residues involved in direct
interactions with seven nucleotides (10). The mutations
of these DNA-interacting residues have been shown to
induce the cleavage of novel targets in conjunction with
the abolishment of cleavage at the natural site (8,11–14).
An extensive study of the protein–DNA interactions of the
I-CreI homodimer was used to generate libraries resulting
from the randomization of two, three or even four amino
acids that contact DNA bases, which were screened
against all the potential cognate DNA sequences.
Millions of combinations were screened, resulting in
several hundreds of mutants with locally altered
speciﬁcities that were later on used in a combinatorial
strategy, and expanded to include homodimeric and
heterodimeric variants of I-CreI (15). Following this
approach, we previously achieved a redesigned
meganuclease that targets the human XPC gene (13)
in vivo. Energy calculations further helped to improve
the engineering of meganuclease variants by highlighting
key residues involved in target recognition and speciﬁcity
(12,16,17).
In a similar way, we have generated several artiﬁcial
meganucleases derived from the I-CreI that are capable
of cleaving a DNA sequence from the human
Recombination Activating Gene 1 (RAG1 gene) (8,14).
The RAG1 gene product has been shown to form a
complex with RAG2 that is responsible for the initiation
of V(D)J recombination, an essential step in the matur-
ation of immunoglobulins and T-lymphocyte receptors
(18,19). Their inactivation causes severe combined im-
munodeﬁciency (SCID) due to the absence of T and B
lymphocytes (20–22). SCID represents a model for mono-
genic diseases amenable to ex vivo treatment and certain
types of SCID have already been treated using gene
therapy (23). In this work, we have determined the
crystal structure of the different variants of I-CreI that
display high efﬁciency and speciﬁcity for RAG1 target
cleavage, and thus analyzed the molecular basis for the
new target DNA recognition by the engineered
meganucleases. In vivo experiments demonstrate that
these engineered enzymes are able to induce repair in the
targeted sequences in human cells.
MATERIALS AND METHODS
Protein expression and puriﬁcation
The I-CreI homodimeric mutants were cloned and ex-
pressed as in refs (13,24). The co-expression, puriﬁcation
and storage of the heterodimeric I-CreI derivatives were
carried out as described (13). All the proteins were folded
and possessed biophysical properties similar to those of
the wild type (veriﬁed by circular dichroism and NMR;
data not shown), and their oligomeric states in solution
were identiﬁed by analytical ultracentrifugation.
Mass spectrometry
Mass determinations of intact proteins were performed
(13) and the intact protein predominantly gave multiply
protonated molecules corresponding to molecular
masses of M=19634/19906Da (V2/V3), obtained by
deconvoluting the multiply charged ions (data not
shown) using MagTran software v.1.02 kindly provided
by Dr Zhongqi Zhang (25). The mass determination of
dissolved crystals was performed as described (13).
Biochemical and biophysical characterization
Circular dichroism (CD) measurements were performed as
before (24). Analytical gel-ﬁltration chromatography was
done at room temperature with an A ¨ KTA FPLC system
(GE) using a Superdex
TM 200 10/300 GL column in
20mM sodium phosphate buffer at pH 6.0 and 1M
NaCl 100ml of the scV3V2(G19S) protein was injected at
0.3mg/ml concentration and eluted from the column at a
ﬂow rate of 0.2ml/min.
Heterodimer stability
The heterodimer dissociation and formation of
homodimers were checked over a period of 3days as
described (13). Brieﬂy, 4.5mg of I-CreI V2V3 or
V2(K7E-G19S)V3(E8K) heterodimers and I-CreI V2
His6-tagged homodimer as control were incubated at
37 C for 0, 1, 2, 4 and 72h (lanes 1–5) (0 h for the
730 Nucleic Acids Research, 2011,Vol. 39,No. 2control His6-tagged homodimer, lane 6). After incubation,
the solutions were mixed with Strep-Tactin Superﬂow resin
(IBA, Gmbh) or Talon Superﬂow resin (Clontech) loaded
with Co
2+ for 25min at room temperature, then
centrifuged and the supernatants loaded on 18%
acrylamide-SDS gel to monitor the heterodimer dissoci-
ation. If homodimer formation takes place during that
time, the homodimer containing the Strep-tag should not
bind to the resin and must stay in the supernatant thus
appearing as a band in the gel. The absence of this band
demonstrates the stability of the selected heterodimer over
this period of time. Lanes 7 and 8 correspond to the I-CreI
V2 His6-tagged homodimer control and the I-CreI V2V3
heterodimers incubated without resin (Figure 1b). For all
the heterodimers: V2 variants contain a His6 tail and V3
variants contain a Strep-tag tail. The quantiﬁcation of the
remaining heterodimers after incubation was performed by
measuring the intensity of the bands in the scanned gels
using ImageJ software (rsb.info.nih.gov/ij/).
Analytical ultracentrifugation
The sedimentation velocity experiment was carried out as
described (24).
In vitro cleavage assay conditions
The in vitro cleavage assay conditions were the same as
those previously described (14).
Fluorescence polarization-binding assays
Solutions containing 25nM 6-FAM-DNA and various
concentrations (0–400nM) of I-CreI proteins were
prepared in a total volume of 50ml binding buffer
(10mM Tris–HCl pH 8, 300mM NaCl and 10mM
CaCl2). Following incubation at 37 C for 10min, the
ﬂuorescence polarization was measured with a Wallac
Victor
2V 1420 Multilabel HTS counter (PerkinElmer).
The dissociation constant (KD) was determined by
non-linear least squares ﬁtting (Prism, GraphPad).
Crystallization
Dynamic light scattering indicated essentially monodis-
perse solutions. The 24-bp-long RAG target DNA was
purchased from Proligo and consisted of two strands of
the following sequence: 50-TTGTTCTCAGGTACCTCA
GCCAGA-30 and 50-TCTGGCTGAGGTACCTGAGAA
CAA-30, which form a 24-bp blunt-end duplex on mixing,
heating and cooling. The protein–DNA complex was
obtained in the presence of either 2mM CaCl2 [for
V2(K7E-G19S)/V3(E8K) and scV3V2(G19S)] or MgCl2
(for V2/V3) and MnCl2 [for scV3V2(G19S)] to obtain
the bound and cleaved states of the target DNA, respect-
ively, by pre-warming the meganuclease and the oligo-
nucleotide samples at 37 C and mixing them in a 1.5:1
molar ratio (DNA:protein). The mixture was incubated
for 50min at this temperature, and then spun down for
5min to remove insoluble material. The ﬁnal concentra-
tion of protein in the DNA–protein complex solution was
4mg/ml. Crystals were grown using the hanging-drop
method at 290K, in 2ml droplets formed by 1ml of the
DNA–protein complex and 1ml of precipitant solution
consisting of 0.2M ammonium acetate and 15% (w/v)
PEG-4000 in 0.1M sodium citrate pH 5.6 for
V2(K7E-G19S)/V3(E8K)–DNA–Ca
2+ and 40% (v/v)
1,2-propanediol, 0.05M calcium acetate in 0.1M calcium
acetate pH 4.5, in the case of V2V3–DNA–Mg
2+. The
crystallization conditions for the scV3V2(G19S) were the
same in the presence of Ca
2+ or Mn
2+ (20% (v/v) PEG
400, 0.1M MES pH 6.5, 5% (v/v) ethanol and 10% (v/v)
ethylene glycol). V2(K7E-G19S)/V3(E8K)–DNA–Ca
2+
crystals were cryo-protected by adding 35% (v/v)
methanol and 20% (v/v) glycerol to the mother liquor,
while V2V3–DNA–Mg
2+ and scV3V2(G19S) crystals
were directly cooled in liquid nitrogen.
Data collection, structure solution, model building,
reﬁnement and structural analysis
All data were collected at 100K, using synchrotron radi-
ation at the PX beam line (SLS, Villigen, Switzerland).
The diffraction pattern was recorded on a Mar225 CCD
or Pilatus detectors. Data processing and scaling were ac-
complished with XDS (26) or MOSFLM (27) (see
Supplementary Table SI). The structures were solved by
molecular replacement as implemented in the programs
MOLREP (28) or PHASER (29). The search model was
based on a poly-alanine backbone derived from the PDB
entry 1G9Z (I-CreI–DNA–Mg
2+). The structures were
then subjected to iterative cycles of model building and
reﬁnement with O (30), Coot (31) and PHENIX (32).
The identiﬁcation and analysis of the protein–DNA
hydrogen Bonds and van der Waals contacts was done
with the Protein Interfaces, Surfaces and Assemblies
service PISA at the European Bioinformatics Institute
(http://www.ebi.ac.uk/msdsrv/ prot_int/pistart.html).
Quantum chemical calculations
Taking cue from the mechanism proposed by Ivanov et al.
for endonuclease IV (33), we built a reaction path con-
necting the crystallographic structures containing (i) the
cleaved DNA and (ii) the non-cleaved DNA. The reaction
path was obtained by formation of the phosphorus
bond with the oxygen of the deoxyribose and cleaving
the hydroxyl-phosphorus bond (Figure 4). At each step,
all the atoms not directly involved in the reaction were
fully relaxed. The system was divided into two parts
using ONIOM (34). The quantum-mechanical part,
formed by the phosphate group, the manganese ion and
its ligands, was modeled via density functional theory
using the B3LYP functional and a 6-311G(d,p) basis set.
The non-quantum mechanical part, including all the
atoms within a distance of 8A ˚ from the reacting phos-
phate, interacts with the QM subsystem by electronic
embedding. After full relaxation, the reaction
path (Figure 4) remained close to that of reference (33)
conﬁrming the validity of the initial guess. The potential
energy proﬁles of the WT as well as the single- and double-
G19S meganuclease mutants are reported in Figure 4. The
energy differences between the penta-coordinate phos-
phorus and the non-cleaved DNA are 16kcal/mol and
14kcal/mol for the WT and G19S meganucleases,
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experimentally hampers the catalysis, shows the highest
energy barrier (17.5kcal/mol).
The difference of the electronic densities between the
wild-type and the single mutant is shown in Figure 4.
From the ﬁgure, it is apparent that the mutation signiﬁ-
cantly polarizes the reacting hydroxyl group, effectively
lowering the reaction barrier. These results, consistent
with the experimental data, clearly support the role of
the single mutation in the transition state of the DNA
cleavage, which was reported to be the rate-limiting step
in the DNA cleavage by endonucleases (33).
In silico speciﬁcity and DNA variability analysis
To predict ‘in silico’ the target speciﬁcity of the three struc-
tures with non-cleaved DNA, that is, the wild-type I-CreI
(1G9Y), and the RAG1 binding proteins V2(K7E,
G19S)V3(E8K) and scV3V2(G19S), we used the protein-
design tool FoldX (35,36). First, the positions of the
amino acid side chains and bases in the crystal structure
were energetically optimized using the FoldX RepairPDB
function. Then, each DNA base was mutated to the other
three bases ﬁve times to increase the conformational space
analyzed (FoldX does not guarantee convergence of
the solution, since depending on the rotamers that
are randomly selected from the library and the order
of movement of the neighboring residues, it can offer
different results due to occasional energy traps). Using
the average value, the difference in protein–DNA inter-
action energy with respect to the wild-type (Gint) was
calculated. To this difference, we added the difference in
intramolecular clashes if they were 0.6kcal/mol higher
than that for the crystal structure (a residue can have
good binding energy to DNA but be in a conformationally
strained position with respect to the molecule to which it
belongs). This function is graphically displayed as infor-
mation content by means of the R package seqLogo,
where the height of a given nucleotide is proportional
to exp( Gint/RT). In all the cases, the same physical
conditions were assumed for the calculations: temperature
of 298K, pH of 7.0 and ionic strength of 150mM.
To analyze the variability allowed at each nucleotide
position that each DNA structure can tolerate on its own,
we ﬁrst mutated each triplet base pair in the DNA to all
64 possiblecombinations. Then, weevaluated thebase-pair
energies for the central base of all triplets. We averaged
these energies, removing those resulting in an increase in
base–base intramolecular or torsional clashes, above the
FoldXstandarddeviation(0.8kcal/mol)(35).Theresulting
averages for the two different DNA base pairs are
GAT= 1.8±0.9 and GCG= 2.8±1.1kcal/mol.
We then considered as a valid context (out of the
16 possible combinations), for a nucleotide in a given
position and structure, those that had a base-pair energy
within 1kcal/mol of the above averages.
Expression of meganucleases in mammalian cells
To avoid construct-stability issues, the two coding
sequences fused in single-chain molecules contain silent
mutations, and share only 72% nucleic acid sequence
identity. Like I-CreI, the N-terminal mutant has
163 residues while the C-terminal mutant sequence
begins at residue Asn6. Details of constructs are available
upon request. The open reading frames of different
meganucleases were ampliﬁed and the expression done
as before (14).
Gene-targeting experiments
The human 293H and MRC5 cell lines were cultured in
DMEM or MEM medium (Invitrogen Life Science),
respectively, supplemented with 2mM L-glutamine, peni-
cillin (100IU/ml), streptomycin (100mg/ml), amphotericin
B (Fongizone) (0.25mg/ml) (Invitrogen Life Science) and
10% FBS (PAA Invitrogen Life Science). Gene-targeting
experiments were carried out in 293H and/or MRC5 cell
lines. The donor plasmid for gene-targeting experiments
contained left and right homology arms generated by
polymerase chain reaction (PCR) ampliﬁcation of the
human RAG1 locus. An exogenous DNA fragment was
inserted between these two arms. These sequences
consisted of a 1.7kb DNA fragment derived from a
neomycin expression plasmid. A donor plasmid carrying
one nucleotide mutation in its homologous right arm was
also designed. The mutation was located 265bp down-
stream of the double-strand break. To prevent cleavage
of the repair matrix by the meganuclease targeting
the human RAG1 locus, a 9bp deletion (comprising
the nucleotides +4 to +12 from the meganuclease DNA
target sequence) was also introduced. A day prior to trans-
fection, cells were seeded at 1 10
6 (293H) and
5 10
5(MRC5) cells per 10-cm dish. Cells were trans-
fected with 3mg of the meganuclease expression vector
(14) and 2mg of matrix vector, in the presence of
lipofectamine 2000 (293H cells) or polyfect (MRC5 cells)
transfection reagent in accordance with the manufactur-
er’s protocol (Invitrogen). After 48h of incubation at
37 C, cells were treated with trypsin and dispensed at a
density of 10 or 100 cells per well in 96-well plates. DNA
was extracted with the ZR-96 genomic DNA kit (Zymo
research) according to the manufacturer’s protocol. PCR
ampliﬁcation reactions performed with speciﬁc primers
enabled us to selectively amplify gene-targeting events.
Gene-insertion events were determined by speciﬁc PCR
ampliﬁcation carried out using a primer speciﬁc to the
exogenous sequence (50-AGGATCTCCTGTCATCTC
AC-30) and a primer speciﬁc to the RAG1 locus (50-CTT
TCACAGTCCTGTACATCTTGT-30). For polymorph-
ism analysis, PCR ampliﬁcations were performed with a
primer speciﬁc to the RAG1 locus (50-TTCACTGCTCTT
CATGGCCTCCC-30) and a primer overlapping with the
9bp deletion of the DNA repair matrix (50-GTTCTCAG
GTACCATGGCAGC-30). Meganuclease-induced muta-
genesis was performed in 293H cells by transfecting
them with 3mg of the meganuclease expression vector
and 2mg of repair-matrix vector. As a negative control,
empty vector alone was also used for transfection.
After 48h of incubation at 37 C, cells were treated with
trypsin, re-plated and individual clones were picked and
subsequently ampliﬁed. After 21days, DNA was extracted
Nucleic AcidsResearch, 2011, Vol.39,No. 2 733with the ZR-96 genomic DNA kit and PCR ampliﬁcation
on RAG1 locus was performed with the primers
F9: 50- GGCAAAGATGAATCAAAGATTCTGTC
CT-30 and
R9: 50-GATCTCACCCGGAACAGCTTAAATT
TC-30. Mutagenesis events were determined by sequencing
the PCR products.
RESULTS
Strategy for generation of the RAG1 variants
In a previous study (14), we scanned the sequence of
the human RAG1 gene (NM_000448.1, NCBI nucleotide
data base) for 22-bp sequences that could be potential
targets of an I-CreI variant resulting from our combina-
torial strategy. Eighteen DNA hits were identiﬁed, and the
most promising one was located before the ATG codon
of the human RAG1 gene (Figure 1a). This hit was
then chosen to screen combinatorial libraries of I-CreI
variants to repair mutations reported in the human
RAG1 gene (20,21). Two combinatorial libraries of
I-CreI variants cleaving the left- (LL) or right-hand
(RR) palindromic sequences were generated, and a set of
active heterodimeric variants cleaving the RAG1 sequence
was identiﬁed. Target cleavage by this heterodimeric
protein was further improved by random mutagenesis
(12,13), resulting in the design of a new heterodimeric
protein called V2V3, which displays high cleavage levels
in yeast and CHO cells (14). However, the formation of
the V2V3 heterodimer inside the cell requires
co-expression of both V2 and V3, which results in a
certain proportion of homodimers as by-products of the
heterodimer formation (Figure 1b, upper panel). The
presence of these homodimers decreases the overall
efﬁciency and speciﬁcity of the engineered meganuclease,
promoting deleterious effects in cells. To avoid these
potentially toxic side effects, we redesigned this enzyme
based on the I-CreI scaffold, ﬁrst by modiﬁcation of the
dimerization interface to ensure heterodimerization
(Figure 1b, lower panel), and second by the creation of
a single-chain molecule joining the two monomers with a
linker loop (Supplementary Figure SF1) (14). After
checking the homodimeric conversion of the heterodimers
(Figure 1b, ‘Material and Methods’ section), we noticed
that the recovery of the V2 homodimer (tagged with the
His6 sequence) was 5–15% (Figure 1b, right upper panel)
and that of the V3 homodimer (tagged with the Strep
sequence) ranged from 30 to 40% (Figure 1b, left upper
panel). However, no homodimer formation could be
observed when the same procedure was applied to the
V2(K7E-G19S)V3(E8K) heterodimer (with the corres-
ponding protomers tagged with the same Strep and the
His6 sequences as above; Figure 1b, lower panels),
indicating an increased stability of this variant due to
the new inter-protomer interface). The mutation G19A
was found in a number of active I-CreI variants (12,13)
optimized by random mutagenesis, and the G19S
mutation was serendipitously discovered to increase the
speciﬁcity of the V2V3 heterodimer toward its
non-palindromic DNA sequence (14).
These heterodimeric variants and some of the precursor
homodimeric ones were subjected to biochemical and bio-
physical characterization (Figure 1c and d). Analytical
ultracentrifugation sedimentation velocity analysis
indicated that all the variants behave as dimers in
solution (with a molecular mass that is double that of
the I-CreI monomer of 20kDa) including the monomeric
single-chain variant scV3V2(G19S). This fact was also
conﬁrmed by size-exclusion chromatography. The
analysis of the in vitro cleavage activity showed that all
the variants behaved similar to the wild-type I-CreI with
C50 between 5 and 8nM (Figure 1d).
The crystal structures of V2V3, the dimerization-
interface-modiﬁed-variant V2(K7E-G19S)V3(E8K) and
the single-chain scV3V2(G19S) variant in complex with
the RAG1 DNA were solved by molecular replacement
(Figure 2, Supplementary Figure SF1 and Table SI).
Overall, the structures of the protein moieties were
similar to that of wild-type I-CreI (0.48–0.65A ˚ Ca
r.m.s.d.), but the structure of the DNA duplex shows
distortions with respect to the I-CreI wild-type DNA.
Speciﬁc protein loops change their local conformation to
ﬁt DNA changes.
Analysis of the protein–DNA complexes
The I-CreI RAG1 variants display mutations clustered in
two different DNA-binding subdomains, and cleave a
RAG1 target sequence, which is different from the palin-
dromic I-CreI C1221 target site of 22bp (15). The residues
that contact the bases at positions ±8, ±9 and ±10 or
±3, ±4 and ±5 were those mutated and screened for
cleavage against an array of DNA sequences differing at
these same positions (Figures 1a and 2). Consequently, the
main structural changes in the protein moiety of the
complex are located in the loops among K28-H37
(Figure 3a and b), the b–strand following it, P113-D120
(Figure 3a and c), and the loop between positions R68 and
S79 (Figure 3a and d). For a detailed description of the
protein–DNA interactions, see Supplementary Data and
Supplementary Figures SF2 and SF3.
The selected mutations efﬁciently recognize and cleave
the new DNA target. The symmetric recognition pattern
of the wild-type protein is exchanged for the asymmetric
pattern of the V2V3, the heterodimer stability improved in
V2(K7E-G19S)V3(E8K) and the speciﬁcity further
enhanced in scV3V2(G19S). This transformation induced
by the engineering approach combines a reduction of
the total number of contacts between the amino acids
and the nucleic acid, with an increase in the proportion
of hydrogen bonds along the new target-DNA major
groove (Supplementary Figure SF3). It is noteworthy
that the conformation of the RAG DNA differs from
that of the wild type, with the largest differences localized
in the major groove. The width of the major groove is
1–4A ˚ larger in the RAG target (depending on the
region) than in the wild-type DNA, exposing a larger
area to the protein. The conformational changes in the
minor groove are less prominent, and as in the wild
type, the RAG variants do not use this region of the
DNA to effect recognition. Interestingly, the four central
734 Nucleic Acids Research, 2011,Vol. 39,No. 2base pairs of the wild-type target sequence, where catalysis
takes place, are found in a distorted minor groove with
the bases at position ±1 and ±2 in both strands having
van der Waals interactions with the protein. This pattern
is altered in the RAG variants. The heterodimer V2V3
does not display any interaction with the ±1 and ±2
bases. However, the variants that contain the G19S
mutation do show interactions in this region.
The linker introduced in the scV3V2(G19S)
meganuclease variant contains 32 residues that cannot
be observed in the electron-density map (Supplementary
Figure SF1), probably due to the loop’s high ﬂexibility. A
similar situation was observed in the crystal structure of a
single-chain variant based on I-MsoI (37), another
member of the LAGLIDADG family, where only a few
residues could be modeled. In our case, only one of the
initial alanines was modeled into the electron density,
indicating where the linker begins. The presence of the
linker did not introduce signiﬁcant changes in the I-CreI
scaffold.
Figure 2. Structures of the RAG variants. Crystal structures of the V2V3 (a) and V2(K7E-G19S)V3(E8K) (b) heterodimeric variants in complex with
the RAG DNA target. (c) Mutations in each monomer are depicted in magenta for V2, yellow for V3, orange for V2(K7E-G19S) and violet for
V3(E8K). The V2(K7E-G19S)V3(E8K) variant contains the same mutations as V2V3 plus K7E, G19S and E8K mutations. The regions of DNA with
the new amino acid contacts are shown in bold. Phosphodiester bonds cleaved by the enzyme are indicated by blue triangles.
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The DNA cleavage reaction in I-CreI has been extensively
studied (38). However, there are open questions regarding
the relevance of DNA bases located at the central pos-
itions ±2, ±1 in cleavage and speciﬁcity of the
enzyme-DNA recognition (Figures 1a and 2c). These
bases show van der Waals interactions with the protein,
plus the interaction of the phosphate group between nu-
cleotides  2 and  1 with the side chain of K139. We have
found that the inclusion of the G19S mutation in the V2 or
V3 monomers resulted in a large decrease in homodimer
cleavage activity against their corresponding LL and RR
DNA targets, displaying a correlation between the in vitro
cleavage and the in vivo measurements (14). In contrast, its
presence-enhanced cleavage activity against the LR target
was observed when the G19S mutation was included in
one of the protomers of the heterodimers. An additional
increase in speciﬁcity is achieved for the LR target with
the monomeric scV3V2(G19S) over the heterodimeric
V2(G19S)V3.
The variant V2(K7E-G19S)V3(E8K), which displays
maximal cleavage of the LR with high speciﬁcity, was
chosen for further characterization. As previously
mentioned, there are no interactions with the bases of
the central four base pairs. G19 is close to the catalytic
D20 and the metal centers involved in the cleavage of
the phosphodiester bonds (Figure 4). In the V2V3
heterodimer, G19 interacts through its backbone
carbonyl with one of the catalytic Mg
2+ and is in the
neighborhood of the carboxyl of D20 in the other
monomer and a phosphate from the digested DNA. The
G19S [V2(G19S)V3 and V2(K7E-G19S)V3(E8K)]
mutants maintain these interactions, and through the
side-chain hydroxyl, form a hydrogen bond with the
backbone carbonyl of G15 in the other monomer. A
close look at the structures indicates that the presence
of S19 in both monomers would promote a steric clash
that could hamper catalysis due to the distortion of the
catalytic centre including the position of D20 in both
monomers. A single G19S mutation in the heterodimer
Figure 3. Structural analysis of I-CreI wild type, V2V3, V2(K7E-G19S)V3(E8K), scV3V2(G19S)-Mn
2+ and scV3V2(G19S)-Ca
2+ with DNA.
(a) Cartoon representation of I-CreI wild type (1G9Y). Mutations in magenta for V3 and yellow for V2 in the three loops where the major
differences with respect the wild type are present, and which might affect some aspect of the binding to the DNA chain. Detailed views in
panels (b), (c) and (d), highlight the structural changes in the protein and DNA molecules. Left: the proteins displaying amino acid side chains
deﬁning the loops, including the wild type DNA in cartoon representation; Right: Ca superposition of all the proteins and their corresponding
DNA molecules. Bases from the Strand B are labeled in all the panels, and boxes with the color code used for each molecule are added for clarity.
(b) The K28-H37 loop, and 8–11 bases of the bound DNA. (c) The P113-D120 loop and bases 7–9. (d) The R68-S79 loop and bases 1–3.
736 Nucleic Acids Research, 2011,Vol. 39,No. 2does not cause substantial conformational changes in
this region. The enhancer effect of the G19S mutation
was observed in several in vivo tests, with different
proteins (14).
To decipher this effect, we performed quantum chem-
istry and quantum mechanical/molecular mechanical
(QM/MM) calculations on the role of the mutation on
the activation energy barrier of the DNA cleavage
reaction (Figure 4b). Using a similar approach as the
one adopted to study the mechanism of the endonuclease
IV (33), we built a reaction path connecting the crystallo-
graphic structures containing the cleaved DNA and the
non-cleaved DNA. The results are in agreement with
the experiments in showing that the single G19S
mutation lowers the activation energy of the reaction
(Figure 4c). The energy difference between the transition
state and the non-cleaved DNA is 16 and 14kcal/mol for
the V2V3 and the V2(G19S)V3 heterodimers, respectively
(Figure 4 and Supplementary Data). These results agree
with the experimental observation. Thus, the introduction
of the G19S mutation only in one monomer increases
the activity of the heterodimer (14). The calculations on
a model structure of the V2(G19S)V3(G19S) heterodimer
yielded a barrier of 17.5kcal/mol, larger than that for
Figure 4. The G19S mutation. (a) Detailed view of the G19S mutation in the V2(K7E-G19S)V3(E8K) heterodimeric protein bound to the RAG1
DNA duplex. A 3Fo 2Fc map calculated at 2.3A ˚ and contoured at 1s, showing both the catalytic D20 residues, the G19S mutation in the V2 chain
as well as the position of G15 and F16. The calcium atoms are colored in yellow and the DNA chain in purple. (b) Scheme of the reaction
mechanism for DNA cleavage. (1) uncleaved DNA, (2) intermediate state with the formation of the pentacoordinated phosphorus atom—the two
bonds involved in the reaction are colored in green and (3) cleaved DNA. (c) Energy proﬁle of the P-O bond break between the phosphorus atom
and the hydroxyl group. Black line: double mutant G19S-G19S modelled in the scV3V2(G19S) structure. Green line: I-CreI, G19-G19. Red line:
scV3V2(G19S). The points at 3.2A ˚ correspond to the uncleaved DNA. (d) Enlargement of the catalytic centre of the wild type heterodimeric protein
with a representation of the electronic density difference between wild type and single mutant (G19S). The isodensity surfaces in blue (red) corres-
pond to an increase (decrease) in the electronic density due to the G19S mutation. The two glycines mutated in the single and double G19S variants
are colored yellow.
Nucleic AcidsResearch, 2011, Vol.39,No. 2 737V2V3, in agreement with the undetectable activity found
for the heterodimers containing the G19S mutation in
both monomers. As the breaking of the bond between
the oxygen O30 and the phosphorus was found to be the
rate-limiting step in Endonuclease IV (33), these calcula-
tions provide computational and theoretical support to
the biochemical ﬁndings.
Computational analysis of protein–DNA recognition
In silico analysis of the sequence–structure relationship of
the DNA from I-CreI, and the RAG1 variants’ structures
using FoldX (35,36) reveals how the conformations of
residues in the previously mentioned loops (K28-H37
and A113-D120) inﬂuence DNA sequence recognition by
the I-CreI scaffold. Some of these conformations may not
promote the recognition of certain DNA sequences. This
could help to explain the high energies observed for the
RAG1 variants bound to the wild-type DNA
(Supplementary Table SII). For example, the combination
of the N30R mutation in V2 and the substitution of
 2CstrandA of the wild-type target by a  2TstrandA
promotes a movement of the loop away from the DNA
(Figure 3). The thymine enforces a small shift of the DNA
and the protein cannot ﬁt an arginine in this region
without moving the whole loop at once (same in the
case of R70S in the 68–75 loop) (Figure 3). In addition,
we observed that the R38 and R40 residues (Figure 3)
force the DNA structure to move away from the
protein, with concomitant changes in the tilting angles
of the two new contacting bases. This movement therefore
reveals that both the protein moiety and the nucleic acid
change their conformation upon complex formation.
Large losses of stability or a signiﬁcant loss of interaction
energy were observed while taking into account the DNA
structure alone (except in the 2VBJ structure,
Supplementary Table SIII).
Inﬂuence of the DNA conformation in recognition
The superposition of the protein–DNA complexes using
the protein Ca backbone reveals differences between the
wild-type DNA and the RAG1 target conformation in the
complexes (Figure 5a). Main differences can be observed
Figure 5. Overlay of the DNA structures. (a) Comparison of the RAG DNA conformations with those of the wild type DNA target. (b) In silico
analysis of the non-cleaved DNA structures. For every nucleotide in each position of the DNA, the number of energetically possible combinations of
surrounding nucleotides (out of 16) is shown. Less speciﬁc positions allow for different bases one position upstream or downstream, while highly
speciﬁc positions are restricted to just a few combinations.
738 Nucleic Acids Research, 2011,Vol. 39,No. 2in the DNA around positions  10 to  3 and 3 to 10 in
strand A and their corresponding base pairs in strand B.
These regions contain the ±10 to ±7 and ±3 to ±5
positions that were scanned during the combinatorial
approach to search for new variants. We have used
FoldX (35) to evaluate the tolerance to nucleotide vari-
ability at each position of the non-cleaved DNAs in the
structures of the wild-type, V2(K7E-G19S)V3(E8K) and
the scV3V2(G19S) complexes. The energies were
calculated taking into account the 16 possible combin-
ations of the surrounding base pairs. This analysis
ranks the 64 possible triplets centered on a given
position by their energy. The graph in Figure 5b shows
the number of energetically favorable allowed triplets
classiﬁed by the identity of the base at that position.
We observe that position ±3 is always very restrictive
and that the central four bases are more restrictive
than the rest of the sequence. The comparison of
the three Ca
2+ bound structures shows that the DNA
duplex bound to V2(K7E-G19S)V3(E8K) variant and
the scV3V2(G19S) displays a higher degree of tolerance
to base-pair variability while the wild-type DNA structure
allows a minor degree of variability, with several positions
only permitting an AT base pair (Supplementary
Figure SF4). This is consistent with the higher
DNA-binding afﬁnity of the wild type when compared
with scV3V2(G19S) (Supplementary Figure SF5).
Gene-targeting efﬁciency with the use of single-chain
meganucleases
A mutation in the human RAG1 gene has been shown to
be present in several patients with Omenn’s syndrome, an
autosomal recessive form of SCID (39). This mutation is
characterized by a two base-pair deletion 368A/369A
(21) and introduces a frame shift at K86 that leads to
the addition of 32 amino acids before a premature stop
codon is encountered. Thus, we designed a DNA-repair
matrix for gene correction, carrying one nucleotide
mutation in its homologous region 265-bp downstream
of the DSB site as a marker (Figure 6a and b). The
repair matrix also contains a 9bp deletion in the RAG1
recognition site. This deletion prevents cleavage of the
repair matrix by the meganuclease and permits the
speciﬁc detection of homologous recombination events
by using a PCR primer that covers the deletion. After
co-transfection of the repair matrix and the
scV3(K7E-K96E)V2(E8K-E61R-G19S)-expressing vector
(14), cells were seeded and cultured, and a 2kb DNA
fragment including the marker was ampliﬁed by speciﬁc
PCR in order to detect gene-correction events. The
estimated gene-correction events occurred in 5.3% of
the transfected cells (Table 1). The meganuclease variant
used in this analysis combined the redesigned interface
and the linker of the single-chain variant that have been
structurally characterized. The PCR-positive wells were
analyzed by DNA sequencing and the frequency of the
marker conversion was determined. In contrast to
previous data (40), the single nucleotide polymorphism
was observed in 66% of the analyzed pools, showing
that a conversion tract of at least 265bp in length
occurred in up to two-third of the targeted cells (Table 1).
The generation of site-speciﬁc DNA double-strand
breaks is a powerful tool for genome engineering. When
a meganuclease and a repair matrix are artiﬁcially
introduced into the cell, they will trigger homologous re-
combination events at the meganuclease cleavage site and
induce gene insertion or gene correction (Figure 6a).
Alternatively, in the absence of a repair matrix,
non-homologous end joining (NHEJ), an error-prone
process that restores the initial sequence or results in
small insertions or deletions of various sizes, will repair
the DSB. These three endonuclease-based strategies
(Figure 6a) are at the origin of the potential applications
of this technology in the ﬁeld of gene therapy. Therefore,
we investigated the efﬁciency of meganucleases to promote
different targeted approaches (Figure 6b).
In the present work, the ability of meganucleases to
stimulate gene targeting (GT) in human cell lines was
evaluated. As the chromatin accessibility might modulate
the cleavage efﬁciency in a locus-dependent manner and
thus affect the GT frequency, we quantiﬁed GT efﬁciency
in two different cell types: the 293H (ATCC CRL-1573)
cells and the normal diploid human cell line MRC5
(ATCC CCL-171) immortalized with SV40 large T
antigen. Moreover, we also determined in these cell lines
the recombination frequency induced by the heterodimeric
variant V2(G19S)V3, the scV3V2(G19S) and the
combined single-chain meganuclease scV3(K7E-K96E)
V2(E8K-E61R-G19S), bearing the two engineered electro-
static interactions previously described (14). GT events
were analyzed by PCR screen of the transfected cells.
Our screen was ﬁrst validated for its ability to detect GT
events under these conditions (data not shown). The
results of targeted recombination could be achieved in
both cell lines at frequencies up to 5.6% and 4.4% of
the transfected 293H and MRC5 cell pools, respectively
(Table 2). In contrast, no GT event could be detected
when a DNA-repair matrix was introduced in the
absence of meganuclease. Interestingly, the combined
single-chain molecule scV3(K7E-K96E)V2(E8K-E61R-
G19S) was revealed to be the most effective meganuclease
design in both cell lines while the heterodimer
V2(G19S)V3 and its corresponding single-chain version
scV3V2(G19S) display similar abilities to induce targeted
recombination.
NHEJ-dependent mutagenesis represents a powerful
strategy to inactivate genes. Alternatively, it is also a
valuable tool to detect in vivo cleavage activity at the en-
dogenous site (Figure 6a). Indeed, repair of DSB by
NHEJ can lead to mutations, usually small deletions or
insertions at the cleavage site. Hence we investigated the
impact of cleavage by scV3(K7E-K96E)V2(E8K-
E61R-G19S) on NHEJ-dependent mutagenesis. The
293H cells were transfected with the vector expressing
this protein without repair matrix and seeded at low
density. After 3weeks of culture without selection, indi-
vidual cellular clones were analyzed. A 400-bp fragment
surrounding the cleavage site was ampliﬁed by PCR
and sequenced. The 284 DNA sequences were analyzed
and 17 of them (6%) were mutated at the cleavage
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740 Nucleic Acids Research, 2011,Vol. 39,No. 2site (Figure 6c). In contrast, no mutation could be
found within the recognition site when cells were trans-
fected with a plasmid that did not express the
meganuclease gene. It is noteworthy that the major
part of the detected mutations consists of small
deletions of a few nucleotides, with the deletion of nine
nucleotides making up to 50% of the mutagenesis events
(Figure 6c).
DISCUSSION
The generation of heterodimeric species inside the cell
could introduce a new variable affecting speciﬁcity in
meganuclease variants, with the potential to induce
off-target cleavage, because of the undesired homodimers
generated from the co-expression of monomers. Hence,
these by-products could decrease the overall speciﬁcity
of the meganucleases by cleaving additional targets.
Although this effect was not observed in other engineered
variants (13), we noticed a correlation between an increase
in the dissociation of the V2V3 heterodimer in vitro
(Figure 1b) and an increase in its toxicity (14). To
overcome this limitation, we have suppressed homodimer
formation by exploiting the dimerization interface and
single-chain designs (14).
We combined the single-chain design with the
dimerization interface variant, to produce the
scV3(K7E-K96E)V2(E8K-E61R) and scV3(K7E-K96E)
V2(E8K-E61R-G19S) molecules. The addition of the
G19S mutation to V2 or V3 resulted in the largest
speciﬁc decrease in homodimer activity with no decrease
in heterodimer activity (14). We combined various sets of
mutations and assessed the effects of these combinations.
Even though this mutation does not introduce any distor-
tion in the position of the protein main chain, or in the
DNA chain, its presence increases the hydrogen bond
network around the active site and our quantum-
chemistry calculations show an increased polarization of
the water-reacting hydroxyl group during catalysis that
decreases the reaction energy barrier by >2kcal/mol
(Figure 4). Homodimer formation is prevented because
although there is space for one serine at position 19, two
serine residues will result in large van der Waals clashes.
Our study indicates that there are concerted conform-
ational changes that occur between the protein loops and
the DNA target molecule, emphasizing the need for as
many different protein–DNA templates as possible to
computationally design new variants that would target
speciﬁc sequences. This idea also arose from the analysis
of the XPC targeting heterodimers (13). Interestingly, the
DNA structure of the XPC and wild-type DNA targets
show more similarities between them than when compared
with the RAG1 target DNA. The structure of RAG1
DNA is more divergent than that of XPC from the wild
type, even though the change in the sequence with respect
to the wild type is similar in both, 16 and 18bp,
respectively.
Our data show that the use of the LAGLIDADG
scaffold can be generalized to target a good range of
different DNA sequences (12,13,41). This work is a step
toward the generation of a` la carte meganuclease variants
based on the I-CreI scaffold targeting DNA sequences of
interest. However, the analysis and the comparison of
these variants in complex with their targets suggests that
this scaffold could not cover the conformational landscape
of the multiple different DNA target sequences, indicating
that new scaffolds must be explored to overcome this
hurdle.
Table 2. Meganuclease-induced gene targeting
Cells/wells Cells/wells Total
cells
analyzed
a
PCR
positive
Estimated
recombination
frequency
b (%)
293H V2(G19S)V3 10 1012 7 0.8
scV3V2(G19S) 10 2924 26 1
scV3(K7E-K96E)V2(E8K-E61R-G19S) 10 3284 166 5.6
Repair matrix alone 100 13920 0 NA
MRC5 V2(G19S)V3 10 960 8 1
scV3V2(G19S) 10 960 13 1.7
scV3(K7E-K96E)V2(E8K-E61R-G19S) 10 1236 44 4.4
Repair matrix alone 100 2630 0 NA
Gene-targeting efﬁciency was estimated by PCR screening. The 293H and MRC5 cells were transfected with plasmids coding for
various designs of the meganuclease targeting the human RAG1 gene and a repair matrix carrying 1700bp of exogenous
sequence. Cells were then seeded at low density (10cells/well) in 96 well plates. Targeted events were detected by speciﬁc PCR.
aCorrected for plating efﬁciency.
bCorrected for transfection efﬁciency.
Table 1. Frequency of targeted polymorphism induced by
meganuclease
Total
number
cells
analyzed
PCR
positive
(%)
Insertion
polymorphism
(%)
Repair plasmid 2256 0 NA
RAG1 meganuclease
and repair plasmid
2632 139 (5.3%) 27/41 (65.8%)
The 293H cells were transfected with plasmid coding for the
meganuclease targeting the human RAG1 gene and a repair matrix
carrying a polymorphism located 265bp downstream of the DSB.
Nucleic AcidsResearch, 2011, Vol.39,No. 2 741The repair mechanism of these newly designed variants
on the targeted gene locus has also been examined in vivo.
Recent data indicate that only one sequence of 22bp for
every 300bp in a genome can be targeted by a speciﬁc
I-CreI-based meganuclease (42). This limitation could
make the meganuclease-mediated gene-correction
strategy not available for all mutations. Pioneering work
using gene-reporter systems has shown that short
gene-conversion tracts of few dozens of nucleotides pre-
dominate (40) after chromosomal DSB induced gene
conversion. In contrast, it has been recently shown in
plants that targeted mutations could be introduced at a
distant location from the DSB (43). In this work, we have
demonstrated that, in human cells, a mutation located 265
nucleotides downstream of the DSB could be efﬁciently
corrected, suggesting that mutations far away from the
induced DSB also have the potential to be repaired
using this approach.
Altogether, these data show that redesigned endonucle-
ases represent one of the most promising tools for targeted
approaches. The opening of a clinical trial for AIDS
patients has recently shown the maturity of these strategies
(http://www.cirm.ca.gov/content/zinc-ﬁnger-nuclease-
based-stem-cell-therapy-aids-dr1-01490). However, there
is still a ‘quest’ for the best reagents, in other words, the
endonucleases providing the best efﬁcacy–toxicity ratio.
New advances in protein design have allowed the engineer-
ing of new scaffolds, such as meganucleases, and the land-
scape of existing methods is likely to change over the next
few years, providing an exciting and effervescent area of
research which could deliver new genome-editing ‘tools’
that could have a big impact in areas ranging from biotech-
nology to biomedicine.
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